BioSig Technologies Partners with Monetary Metals for Blockchain

BioSig Technologies ( (BSGM) ) has issued an update.

On September 8, 2025, BioSig Technologies entered into a strategic partnership with Monetary Metals to create blockchain-based financial products that tokenize the yield from precious-metal leases and bonds. This exclusive three-year agreement allows Streamex, a subsidiary of BioSig, to tokenize yield-bearing gold products, aiming to provide investors with up to a 4% annual yield. The partnership is expected to bridge traditional gold markets with digital assets, potentially impacting the investment landscape by offering scalable, institutional-grade instruments.

The most recent analyst rating on (BSGM) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on BioSig Technologies stock, see the BSGM Stock Forecast page.

Spark’s Take on BSGM Stock

According to Spark, TipRanks’ AI Analyst, BSGM is a Underperform.

BioSig Technologies faces significant financial difficulties, with persistent losses, high leverage, and negative cash flow trends. While technical analysis indicates some short-term momentum, potential overbought conditions warrant caution. The negative P/E ratio further underscores valuation challenges and risks associated with the stock.

To see Spark’s full report on BSGM stock, click here.

More about BioSig Technologies

BioSig Technologies, Inc. is a medical device technology company known for its advanced digital signal processing technology platform, the PURE EP™ Platform, which provides insights for electrophysiologists in treating cardiovascular arrhythmias. Streamex, a wholly owned subsidiary of BioSig, focuses on tokenizing real-world assets, particularly in the gold and commodities market, using a gold-denominated treasury and tokenization technology.

Average Trading Volume: 1,083,640

Technical Sentiment Signal: Hold

Current Market Cap: $155.5M

For detailed information about BSGM stock, go to TipRanks’ Stock Analysis page.